Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Arf6 regulates RhoB subcellular localization to control cancer cell invasion.

Zaoui K, Rajadurai CV, Duhamel S, Park M.

J Cell Biol. 2019 Oct 7. pii: jcb.201806111. doi: 10.1083/jcb.201806111. [Epub ahead of print]

PMID:
31591185
2.

Tumor Control and Quality of Life in Skin Cancer Patients With Extensive Multilayered Nasal Defects.

Plath M, Thielen HM, Baumann I, Zaoui K, Federspil PA.

Clin Exp Otorhinolaryngol. 2019 Aug 3. doi: 10.21053/ceo.2019.00192. [Epub ahead of print]

3.

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion.

Zaoui K, Boudhraa Z, Khalifé P, Carmona E, Provencher D, Mes-Masson AM.

Nat Commun. 2019 Jun 17;10(1):2666. doi: 10.1038/s41467-019-10570-w.

4.

Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.

Schmitt K, Molfenter B, Laureano NK, Tawk B, Bieg M, Hostench XP, Weichenhan D, Ullrich ND, Shang V, Richter D, Stögbauer F, Schroeder L, de Bem Prunes B, Visioli F, Rados PV, Jou A, Plath M, Federspil PA, Thierauf J, Döscher J, Weissinger SE, Hoffmann TK, Wagner S, Wittekindt C, Ishaque N, Eils R, Klussmann JP, Holzinger D, Plass C, Abdollahi A, Freier K, Weichert W, Zaoui K, Hess J.

Int J Cancer. 2019 May 28. doi: 10.1002/ijc.32481. [Epub ahead of print]

PMID:
31135957
5.

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.

Akbaba S, Held T, Lang K, Hoerner-Rieber J, Zaoui K, Forster T, Rieken S, Plinkert P, Debus J, Adeberg S.

Radiat Oncol. 2019 Feb 19;14(1):34. doi: 10.1186/s13014-019-1238-8.

6.

Impact of Le-Fort I osteotomy on anatomical and functional aspects of the nasal airway and on quality of life.

Zaoui K, Kuehle R, Baumann I, Schuessler DL, Ristow O, Plath M, Freudlsperger C.

Eur Arch Otorhinolaryngol. 2019 Apr;276(4):1065-1073. doi: 10.1007/s00405-018-05277-5. Epub 2019 Jan 14.

PMID:
30643961
7.

CLIP-170 spatially modulates receptor tyrosine kinase recycling to coordinate cell migration.

Zaoui K, Duhamel S, Parachoniak CA, Park M.

Traffic. 2019 Mar;20(3):187-201. doi: 10.1111/tra.12629. Epub 2019 Jan 15.

8.

Primary surgical treatment of nasal vestibule cancer - therapeutic outcome and reconstructive strategies.

Zaoui K, Plinkert PK, Federspil PA.

Rhinology. 2018 Dec 1;56(4):393-399. doi: 10.4193/Rhin17.157.

PMID:
30098234
9.

Quality of life after nasal cancer resection - surgical versus prosthetic rehabilitation.

Zaoui K, Thielen HM, Plath M, Baumann I, Plinkert PK, Federspil PA.

Rhinology. 2018 Dec 1;56(4):400-406. doi: 10.4193/Rhin18.030.

PMID:
30052694
10.

COMMD5/HCaRG Hooks Endosomes on Cytoskeleton and Coordinates EGFR Trafficking.

Campion CG, Zaoui K, Verissimo T, Cossette S, Matsuda H, Solban N, Hamet P, Tremblay J.

Cell Rep. 2018 Jul 17;24(3):670-684.e7. doi: 10.1016/j.celrep.2018.06.056.

11.

Function, Applicability, and Properties of a Novel Flexible Total Ossicular Replacement Prosthesis With a Silicone Coated Ball and Socket Joint.

Stoppe T, Bornitz M, Lasurashvili N, Sauer K, Zahnert T, Zaoui K, Beleites T.

Otol Neurotol. 2018 Jul;39(6):739-747. doi: 10.1097/MAO.0000000000001797.

PMID:
29794685
12.

Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.

Kreycy N, Gotzian C, Fleming T, Flechtenmacher C, Grabe N, Plinkert P, Hess J, Zaoui K.

BMC Cancer. 2017 May 26;17(1):382. doi: 10.1186/s12885-017-3367-5.

13.

Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.

Grünow J, Rong C, Hischmann J, Zaoui K, Flechtenmacher C, Weber KJ, Plinkert P, Hess J.

J Exp Clin Cancer Res. 2017 Feb 6;36(1):25. doi: 10.1186/s13046-017-0496-2.

14.

[Prosthetic treatment of nasal septal perforations : Results with custom-made silicone buttons].

Zaoui K, Schneider MH, Neuner O, Federspil PA.

HNO. 2016 Dec;64(12):897-904. German.

PMID:
27837213
15.

5'-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion.

Rajadurai CV, Havrylov S, Coelho PP, Ratcliffe CD, Zaoui K, Huang BH, Monast A, Chughtai N, Sangwan V, Gertler FB, Siegel PM, Park M.

J Cell Biol. 2016 Sep 12;214(6):719-34. doi: 10.1083/jcb.201501003. Epub 2016 Sep 5.

16.

[Diabetes mellitus as a prognostic marker in oropharyngeal and laryngeal squamous cell carcinoma].

Zaoui K, Doll J, Stiebi P, Federspil P, Plinkert PK, Hess J.

HNO. 2016 Jul;64(7):479-86. doi: 10.1007/s00106-016-0177-z. German.

PMID:
27307061
17.

[Concepts to improve current treatment regimens in head and neck cancer].

Zaoui K, Hess J.

HNO. 2016 Jul;64(7):448-9. doi: 10.1007/s00106-016-0179-x. German. No abstract available.

PMID:
27299889
18.

Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer.

Affolter A, Muller MF, Sommer K, Stenzinger A, Zaoui K, Lorenz K, Wolf T, Sharma S, Wolf J, Perner S, Weber KJ, Freier K, Plinkert PK, Hess J, Weichert W.

Head Neck. 2016 Apr;38 Suppl 1:E2049-61. doi: 10.1002/hed.24376. Epub 2016 Feb 26.

PMID:
26918677
19.

Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.

Seidensaal K, Nollert A, Feige AH, Muller M, Fleming T, Gunkel N, Zaoui K, Grabe N, Weichert W, Weber KJ, Plinkert P, Simon C, Hess J.

Mol Cancer. 2015 Dec 3;14:204. doi: 10.1186/s12943-015-0476-0.

20.

[The epigenome. Target for innovative therapies in head and neck carcinoma].

Leipold A, Hess J, Zaoui K.

HNO. 2015 Nov;63(11):786-91. doi: 10.1007/s00106-015-0075-9. Review. German.

PMID:
26489412
21.

Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.

Schrader CH, Kolb M, Zaoui K, Flechtenmacher C, Grabe N, Weber KJ, Hielscher T, Plinkert PK, Hess J.

Mol Cancer. 2015 May 20;14:107. doi: 10.1186/s12943-015-0381-6.

22.

Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer.

George B, Horn D, Bayo P, Zaoui K, Flechtenmacher C, Grabe N, Plinkert P, Krizhanovsky V, Hess J.

Cancer Lett. 2015 Mar 28;358(2):191-199. doi: 10.1016/j.canlet.2014.12.042. Epub 2014 Dec 24.

PMID:
25543088
23.

[Percutaneous titanium implants for bone conduction hearing aids: experience with 283 cases].

Federspil PA, Koch A, Schneider MH, Zaoui K.

HNO. 2014 Jul;62(7):490-7. doi: 10.1007/s00106-014-2882-9. German.

PMID:
24928518
24.

Clinical investigation of flat panel CT following middle ear reconstruction: a study of 107 patients.

Zaoui K, Kromeier J, Neudert M, Beleites T, Zahnert T, Laszig R, Offergeld C.

Eur Radiol. 2014 Mar;24(3):587-94. doi: 10.1007/s00330-013-3068-7. Epub 2013 Nov 26.

PMID:
24275805
25.

Facial basal cell carcinoma with successive metastases to the neck, thyroid gland and lung.

Thiele OC, Mertens C, Bacon C, Flechtenmacher C, Zaoui K, Mischkowski RA.

J Craniomaxillofac Surg. 2014 Jul;42(5):489-91. doi: 10.1016/j.jcms.2013.06.007. Epub 2013 Jul 9.

PMID:
23849247
26.

[Promising therapy concepts in the treatment of advanced head and neck tumors].

Zaoui K, Praetorius M.

HNO. 2013 Jul;61(7):549-50. doi: 10.1007/s00106-013-2735-y. German. No abstract available.

PMID:
23842697
27.

Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.

Grossardt C, Engeland CE, Bossow S, Halama N, Zaoui K, Leber MF, Springfeld C, Jaeger D, von Kalle C, Ungerechts G.

Hum Gene Ther. 2013 Jul;24(7):644-54. doi: 10.1089/hum.2012.205.

28.

[Grafts with microvascular anastomosis. Their use in the head and neck region following radiotherapy and vessel depletion].

Zaoui K, Federspil P, Plinkert PK, Simon C.

HNO. 2013 Jul;61(7):573-9. doi: 10.1007/s00106-013-2673-8. German.

PMID:
23532515
29.

Submaxillary gland androgen-regulated protein 3A expression is an unfavorable risk factor for the survival of oropharyngeal squamous cell carcinoma patients after surgery.

Koffler J, Holzinger D, Sanhueza GA, Flechtenmacher C, Zaoui K, Lahrmann B, Grabe N, Plinkert PK, Hess J.

Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1493-500. doi: 10.1007/s00405-012-2201-6. Epub 2012 Oct 5.

PMID:
23053383
30.

Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia.

Rajadurai CV, Havrylov S, Zaoui K, Vaillancourt R, Stuible M, Naujokas M, Zuo D, Tremblay ML, Park M.

J Cell Sci. 2012 Jun 15;125(Pt 12):2940-53. doi: 10.1242/jcs.100834. Epub 2012 Feb 24.

31.

LOH-profiling by SNP-mapping in a case of multifocal head and neck cancer.

Pfeiffer J, Maier W, Ridder GJ, Zaoui K, Birkenhäger R.

World J Clin Oncol. 2012 Feb 10;3(2):24-8. doi: 10.5306/wjco.v3.i2.24.

32.

Flat panel CT following stapes prosthesis insertion: an experimental and clinical study.

Zaoui K, Kromeier J, Neudert M, Boedeker CC, Zahnert T, Laszig R, Offergeld C.

Eur Radiol. 2012 Apr;22(4):837-44. doi: 10.1007/s00330-011-2317-x. Epub 2011 Dec 8.

PMID:
22160168
33.

Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.

Zaoui K, Bossow S, Grossardt C, Leber MF, Springfeld C, Plinkert PK, Kalle Cv, Ungerechts G.

Cancer Gene Ther. 2012 Mar;19(3):181-91. doi: 10.1038/cgt.2011.75. Epub 2011 Nov 11.

PMID:
22076043
34.

[Differential diagnosis of headaches in otorhinolaryngology].

Zaoui K, van de Weyer PS, Plinkert PK, Baumann I.

HNO. 2011 Jul;59(7):645-50. doi: 10.1007/s00106-011-2268-1. German.

PMID:
21509621
35.

MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.

Leber MF, Bossow S, Leonard VH, Zaoui K, Grossardt C, Frenzke M, Miest T, Sawall S, Cattaneo R, von Kalle C, Ungerechts G.

Mol Ther. 2011 Jun;19(6):1097-106. doi: 10.1038/mt.2011.55. Epub 2011 Apr 5.

36.

ErbB2 receptor controls microtubule capture by recruiting ACF7 to the plasma membrane of migrating cells.

Zaoui K, Benseddik K, Daou P, Salaün D, Badache A.

Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18517-22. doi: 10.1073/pnas.1000975107. Epub 2010 Oct 11.

37.

Identification of roles for peptide: N-glycanase and endo-beta-N-acetylglucosaminidase (Engase1p) during protein N-glycosylation in human HepG2 cells.

Chantret I, Fasseu M, Zaoui K, Le Bizec C, Sadou Yayé H, Dupré T, Moore SE.

PLoS One. 2010 Jul 23;5(7):e11734. doi: 10.1371/journal.pone.0011734.

38.

Memo-RhoA-mDia1 signaling controls microtubules, the actin network, and adhesion site formation in migrating cells.

Zaoui K, Honoré S, Isnardon D, Braguer D, Badache A.

J Cell Biol. 2008 Nov 3;183(3):401-8. doi: 10.1083/jcb.200805107. Epub 2008 Oct 27.

39.

High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR).

Schmidt M, Schwarzwaelder K, Bartholomae C, Zaoui K, Ball C, Pilz I, Braun S, Glimm H, von Kalle C.

Nat Methods. 2007 Dec;4(12):1051-7.

PMID:
18049469
40.

A hybrid vector for ligand-directed tumor targeting and molecular imaging.

Hajitou A, Trepel M, Lilley CE, Soghomonyan S, Alauddin MM, Marini FC 3rd, Restel BH, Ozawa MG, Moya CA, Rangel R, Sun Y, Zaoui K, Schmidt M, von Kalle C, Weitzman MD, Gelovani JG, Pasqualini R, Arap W.

Cell. 2006 Apr 21;125(2):385-98.

Supplemental Content

Support Center